ArticleOncoTargets and therapy2018

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1.

Yanfen Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.